Search

Your search keyword '"Angela Tam"' showing total 224 results

Search Constraints

Start Over You searched for: Author "Angela Tam" Remove constraint Author: "Angela Tam"
224 results on '"Angela Tam"'

Search Results

1. The neurophysiological brain-fingerprint of Parkinson’s diseaseResearch in context

2. A landscape of response to drug combinations in non-small cell lung cancer

3. Shared and unique brain network features predict cognitive, personality, and mental health scores in the ABCD study

4. Functional connectivity subtypes associate robustly with ASD diagnosis

5. Comparison of individualized behavioral predictions across anatomical, diffusion and functional connectivity MRI

6. Differential responses of MET activations to MET kinase inhibitor and neutralizing antibody

7. Integrated Molecular Characterization of Testicular Germ Cell Tumors

8. Use of Patterned Collagen Coated Slides to Study Normal and Scleroderma Lung Fibroblast Migration

9. Resting‐state network dysfunction in Alzheimer's disease: A systematic review and meta‐analysis

10. A dataset of multiresolution functional brain parcellations in an elderly population with no or mild cognitive impairment

11. Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles

12. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

13. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

14. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

15. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

16. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

17. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

18. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types

19. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

20. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

21. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

22. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

23. Cognitive Function and 3-Tesla Magnetic Resonance Imaging Tractography of White Matter Hyperintensities in Elderly Persons

24. Separable Roles for a Caenorhabditis elegans RMI1 Homolog in Promoting and Antagonizing Meiotic Crossovers Ensure Faithful Chromosome Inheritance.

25. Use of Physical and Intellectual Activities and Socialization in the Management of Cognitive Decline of Aging and in Dementia: A Review

26. Distinct brain network features predict internalizing and externalizing traits in children and adults

27. Table S6 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

28. Supplementary Data from PCA062, a P-cadherin Targeting Antibody–Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin–expressing Malignancies

29. Supplementary Table S3 from FGFR-Mediated Reactivation of MAPK Signaling Attenuates Antitumor Effects of Imatinib in Gastrointestinal Stromal Tumors

30. Data from PCA062, a P-cadherin Targeting Antibody–Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin–expressing Malignancies

32. Supplementary Data from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

33. Table S2 from PCA062, a P-cadherin Targeting Antibody–Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin–expressing Malignancies

34. Supplementary Figures S1-S15 from High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells

35. Supplementary Table S6 from High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells

36. Data from Capmatinib (INC280) Is Active Against Models of Non–Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation

37. Supplementary Data from Capmatinib (INC280) Is Active Against Models of Non–Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation

38. Supplementary Table and Figure Legends from High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells

39. Supplementary Tables from Capmatinib (INC280) Is Active Against Models of Non–Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation

40. Supplementary Tables 1-2 from Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-α Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase Inhibitors

41. Supplementary Figure 6 from Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-α Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase Inhibitors

42. Data from Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-α Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase Inhibitors

43. Supplementary Methods, Figures 1-8, Tables 1-3 from A Genome-Wide Screen for Microdeletions Reveals Disruption of Polarity Complex Genes in Diverse Human Cancers

44. Supplementary Figure 3 from Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-α Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase Inhibitors

45. Supplementary Figures 1-2 from Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-α Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase Inhibitors

46. Supplementary Figure 4 from Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-α Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase Inhibitors

47. Supplementary Figure 7 from Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-α Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase Inhibitors

48. Supplementary Figure 5 from Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-α Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase Inhibitors

49. Reproducible brain-wide association studies require thousands of individuals

Catalog

Books, media, physical & digital resources